
Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings
Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2019年年度报告披露提示性公告 | 2020-03-20 | Chinese | |
| 2019年度社会责任报告 | 2020-03-20 | Chinese | |
| 募集资金存放与实际使用情况审核报告 | 2020-03-20 | Chinese | |
| 关于拟续聘会计师事务所的公告 | 2020-03-20 | Chinese | |
| 关于2019年度拟不进行利润分配的专项说明 | 2020-03-20 | Chinese | |
| 独立董事关于2019年度相关事项及第四届董事会第七次会议相关事项的独立意见 | 2020-03-20 | Chinese |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 35982102 | 2019年年度报告披露提示性公告 | 2020-03-20 | Chinese | ||
| 35982090 | 2019年度社会责任报告 | 2020-03-20 | Chinese | ||
| 35981696 | 募集资金存放与实际使用情况审核报告 | 2020-03-20 | Chinese | ||
| 35981674 | 关于拟续聘会计师事务所的公告 | 2020-03-20 | Chinese | ||
| 35981662 | 关于2019年度拟不进行利润分配的专项说明 | 2020-03-20 | Chinese | ||
| 35981653 | 独立董事关于2019年度相关事项及第四届董事会第七次会议相关事项的独立意见 | 2020-03-20 | Chinese | ||
| 35981642 | 2019年度独立董事述职报告(钟彬) | 2020-03-20 | Chinese | ||
| 35981632 | 2019年年度报告 | 2020-03-20 | Chinese | ||
| 35981625 | 华创证券有限责任公司关于公司调整部分募集资金投资项目实施主体的核查意见 | 2020-03-20 | Chinese | ||
| 35981611 | 关于玉溪沃森生物技术有限公司向银行申请综合授信及流动资金贷款的公告 | 2020-03-20 | Chinese | ||
| 35981599 | 关于设立全资子公司实施募集资金投资项目的公告 | 2020-03-20 | Chinese | ||
| 35981584 | 关于会计政策变更的公告 | 2020-03-20 | Chinese | ||
| 35981570 | 2019年度财务决算报告 | 2020-03-20 | Chinese | ||
| 35981556 | 内部控制鉴证报告 | 2020-03-20 | Chinese | ||
| 35981543 | 华创证券有限责任公司关于公司调整配套募集资金投资项目达到预定可使用状态时间的专项核查报告 | 2020-03-20 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Walvax Biotechnology Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55154/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55154 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55154 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55154 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55154}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Walvax Biotechnology Co.,Ltd. (id: 55154)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.